Abstract
Mesenchymal stem cells (MSCs) are multipotent adult stem cells present in multiple tissues, such as bone marrow, adipose tissue, umbilical cord, and amniotic fluid. MSCs can differentiate into multilineage cells under defined conditions in vitro and in vivo. MSCs have been shown to have therapeutic effects on various types of diseases. Noninvasive in vivo monitoring of MSCs is considered one of the important techniques for developing cell therapy. In this protocol, we introduce strategized MSCs derived from bone marrow (BM-MSCs) of knock-in mouse model expressing mCherry-Renilla luciferase (mCherry-RLuc) for noninvasive bioluminescence imaging (BLI) of injected BM-MSCs in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gangadaran P, Rajendran RL, Ahn B-C (2020) Application of in vivo imaging techniques for monitoring natural killer cell migration and tumor infiltration. Cancers 12:1318
Rajendran RL, Jogalekar MP, Gangadaran P et al (2020) Noninvasive in vivo cell tracking using molecular imaging: a useful tool for developing mesenchymal stem cell-based cancer treatment. World J Stem Cells 12:1492–1510
Weissman IL, Shizuru JA (2008) The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 112:3543–3553
Murray IR, Péault B (2015) Q&A: mesenchymal stem cells — where do they come from and is it important? BMC Biol 13:99
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403
Lee DE, Ayoub N, Agrawal DK (2016) Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy. Stem Cell Res Ther 7:37
Ukai R, Honmou O, Harada K et al (2007) Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma 24:508–520
Rowart P, Erpicum P, Detry O et al (2015) Mesenchymal stromal cell therapy in ischemia/reperfusion injury. J Immunol Res 2015:e602597
Gjorgieva D, Zaidman N, Bosnakovski D (2013) Mesenchymal stem cells for anti-cancer drug delivery. Recent Pat Anticancer Drug Discov 8:310–318
Oh EJ, Lee HW, Kalimuthu S et al (2018) In vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse model. J Control Release 279:79–88
Gangadaran P, Ahn B-C (2017) Molecular imaging: a useful tool for the development of natural killer cell-based immunotherapies. Front Immunol 8:1090
Lee HW, Gangadaran P, Kalimuthu S et al (2016) Advances in molecular imaging strategies for in vivo tracking of immune cells. Biomed Res Int 2016:1946585
Kim JE, Kalimuthu S, Ahn B-C (2015) In vivo cell tracking with bioluminescence imaging. Nucl Med Mol Imaging 49:3–10
Kim TK, Eberwine JH (2010) Mammalian cell transfection: the present and the future. Anal Bioanal Chem 397:3173–3178
Woods N-B, Muessig A, Schmidt M et al (2003) Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Blood 101:1284–1289
Pfeifer A, Verma IM (2001) Gene therapy: promises and problems. Annu Rev Genomics Hum Genet 2:177–211
Hacein-Bey-Abina S, Le Deist F, Carlier F et al (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346:1185–1193
Yang Y-HK, Ogando CR, Wang See C et al (2018) Changes in phenotype and differentiation potential of human mesenchymal stem cells aging in vitro. Stem Cell Res Ther 9:131
Sareen N, Sequiera GL, Chaudhary R et al (2018) Early passaging of mesenchymal stem cells does not instigate significant modifications in their immunological behavior. Stem Cell Res Ther 9:121
Acknowledgments
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2019R1I1A1A01061296, NRF-2019R1I1A3A01063308 and NRF-2019R1A6A3A13096414) and by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI15C0001).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Gangadaran, P., Oh, J.M., Rajendran, R.L., Ahn, BC. (2022). In Vivo Bioluminescent Imaging of Bone Marrow-Derived Mesenchymal Stem Cells in Mice. In: Kim, SB. (eds) Bioluminescence. Methods in Molecular Biology, vol 2525. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2473-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2473-9_21
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2472-2
Online ISBN: 978-1-0716-2473-9
eBook Packages: Springer Protocols